Robotic single site staging in endometrial cancer: A multi-institution study.

摘要: Abstract Objective To evaluate the feasibility and safety of robotic single site hysterectomy (RSSH) plus or less pelvic lymphadenectomy in FIGO stage I–II endometrial cancer. Materials methods We prospectively collected patient demographics, operative times, complications, pathologic results, length stay on all patients who underwent RSSH for clinical I occult II carcinoma. Results From January 2012 to February 2015, 125 were included our study. The median age was 59 years (range, 35–84 years) body mass index 27 kg/m2 19–52 kg/m2). One converted vaginal surgery due problems hypercapnia. docking time, console total time 11 min 4–40 min), 80 min 20–240 min) 122 min 35–282 min), respectively. blood loss 50 ml 10–250 ml). No laparoscopic/laparotomic conversion registered. Twenty one (16.8%) lymph nodes 13 3–32). discharge 2 days 1–3 days). intra-operative complications occurred, while we observed 10 (8%) early post-operative complications. Conclusion is technically feasible, safe reproducible could be treatment choice affected by However, randomized controlled trials are needed confirm these results.